You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Denosumab

Showing 26 - 50 of 322
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Premenopausal Idiopathic Osteoporosis Trial in New York (Romosozumab Prefilled Syringe [Evenity], Denosumab 60 MG/ML Prefilled

Recruiting
  • Premenopausal Idiopathic Osteoporosis
  • Romosozumab Prefilled Syringe [Evenity]
  • Denosumab 60 MG/ML Prefilled Syringe [Prolia]
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

Postmenopausal Osteoporosis Trial in Seoul (Risedronate Sodium 35 MG [Actonel], Calcium Vitamin D combination)

Not yet recruiting
  • Postmenopausal Osteoporosis
  • Risedronate Sodium 35 MG [Actonel]
  • Calcium Vitamin D combination
  • Seoul, Seodaemun-gu, Korea, Republic of
    Severance Hospital
Nov 29, 2022

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Denosumab
  • +2 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

Osseointegrated Implants, Bone Mineral Density Trial (Denosumab, Placebo)

Completed
  • Osseointegrated Implants
  • Bone Mineral Density
  • Denosumab
  • Placebo
  • (no location specified)
Feb 20, 2023

Diabetes, Type 2, Osteoporosis Trial in New York (Denosumab 60 mg/ml [Prolia], Placebo)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Osteoporosis
  • Denosumab 60 mg/ml [Prolia]
  • Placebo
  • New York, New York
    Columbia University Irving Medical Center - Harkness Pavillion
Aug 1, 2022

This is a Phase Study Conducted in Healthy Volunteers, Osteoporosis Trial (Denosumab)

Not yet recruiting
  • This is a Phase Study Conducted in Healthy Volunteers
  • Osteoporosis
  • Denosumab
  • (no location specified)
May 17, 2023

Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures Trial in Pittsburgh (denosumab, Placebo, Calcium and Vitamin

Active, not recruiting
  • Osteoporosis, Postmenopausal
  • +2 more
  • denosumab
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Senior Communities
Sep 7, 2022

Sarcopenia, Osteoporosis Trial in Pittsburgh (Denosumab, Zoledronic Acid, Denosumab Placebo)

Not yet recruiting
  • Sarcopenia
  • Osteoporosis
  • Denosumab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 2, 2023

Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

Active, not recruiting
  • Bone Diseases
  • Pain
  • Denosumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 17, 2022

Zoledronic Acid to Prevent Bone Loss Following Denosumab

Recruiting
  • Osteoporosis
  • +3 more
  • Zoledronic acid
  • Calgary, Alberta, Canada
    University of Calgary, McCaig Institute for Bone and Joint Healt
Nov 1, 2022

Breast Cancer Trial in Kyoto (Denosumab Injection)

Recruiting
  • Breast Cancer
  • Denosumab Injection
  • Kyoto, Japan
    Hisako Ono
Mar 30, 2022

Breast Cancer Trial in Stony Brook (Denosumab)

Completed
  • Breast Cancer
  • Denosumab
  • Stony Brook, New York
    Stony Brook University Cancer Center
Jan 19, 2022

Healthy Male Subjects Trial in Christchurch (Denosumab)

Recruiting
  • Healthy Male Subjects
  • Denosumab
  • Christchurch, Christchuch, New Zealand
    NZCR: New Zealand Clinical Research
Jan 24, 2023

Postmenopausal Osteoporosis Trial in Uherské Hradište (ENZ215, Prolia)

Recruiting
  • Postmenopausal Osteoporosis
  • ENZ215
  • Prolia
  • Uherské Hradiště, Czechia
    MEDICAL PLUS s.r.o.
Jul 30, 2022

Bariatric Surgery Candidate, Bone Loss Trial in San Francisco, Boston (Denosumab, Placebo, Zoledronic Acid)

Recruiting
  • Bariatric Surgery Candidate
  • Bone Loss
  • Denosumab
  • +2 more
  • San Francisco, California
  • +1 more
Apr 4, 2022

Healthy Trial in Berlin, Hamburg (LY06006 (Denosumab Biosimilar), US-Prolia (Denosumab), EU-Prolia)

Completed
  • Healthy
  • LY06006 (Denosumab Biosimilar)
  • +2 more
  • Berlin, Germany
  • +1 more
Oct 18, 2023

Revision Surgery of Total Hip Arthroplasty Trial in Sheffield (Denosumab, Placebo)

Completed
  • Revision Surgery of Total Hip Arthroplasty
  • Denosumab
  • Placebo
  • Sheffield, South Yorkshire, United Kingdom
    Academic Unit of Bone Metabolism
Feb 1, 2022

Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml

Active, not recruiting
  • Multiple Myeloma
  • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
  • Placebo 1.7 ml Subcutaneous Solution
  • Graz, Austria
  • +9 more
Aug 24, 2022

Bone Complications in People With Post-menopausal Breast Cancer

Recruiting
  • Breast Cancer
  • Physical Evaluation
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 20, 2022

Osteoporosis, Fusion of Spine, Lumbar Region Trial in Shanghai (Denosumab 60 mg/ml Injectable Solution [Prolia], calcium and

Recruiting
  • Osteoporosis
  • Fusion of Spine, Lumbar Region
  • Denosumab 60 mg/ml Injectable Solution [Prolia]
  • calcium and vitamin D
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Jan 20, 2022

Healthy Trial in Newark, Rennes (Denosumab)

Completed
  • Healthy
  • Denosumab
  • Newark, New Jersey
  • +1 more
Nov 24, 2022

Melanoma Stage Iv, Melanoma Stage Iii, Melanoma Trial in Australia (Denosumab, Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma Stage Iv
  • +2 more
  • Denosumab
  • +2 more
  • Albury, New South Wales, Australia
  • +9 more
Apr 6, 2022

Osteoporotic Fractures Trial (Denosumab, Teriparatide)

Not yet recruiting
  • Osteoporotic Fractures
  • (no location specified)
May 9, 2023

Critical Illness, Osteoporosis Trial in Australia (Denosumab 60 MG/ML, Zoledronic Acid 5Mg/Bag 100Ml Inj, Sodium Chloride 0.9%

Recruiting
  • Critical Illness
  • Osteoporosis
  • Denosumab 60 MG/ML
  • +3 more
  • Sydney, New South Wales, Australia
  • +11 more
Sep 26, 2022

Giant Cell Tumor of Bone Trial (XGEVA®)

Not yet recruiting
  • Giant Cell Tumor of Bone
  • (no location specified)
Mar 3, 2022